Sabra Health Care REIT Key Executives
This section highlights Sabra Health Care REIT's key executives, including their titles and compensation details.
Find Contacts at Sabra Health Care REIT
(Showing 0 of )
Sabra Health Care REIT Earnings
This section highlights Sabra Health Care REIT's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-20 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-11-01 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-08-08 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-05-09 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-02-28 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-11-07 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-08-08 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-05-04 | N/A | N/A |
Financial Statements
Access annual & quarterly financial statements for Sabra Health Care REIT, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $703.24M | $647.51M | $624.81M | $569.54M | $598.57M |
| Cost of Revenue | $227.09M | $378.33M | $162.61M | $141.20M | $131.55M |
| Gross Profit | $476.15M | $269.18M | $462.20M | $428.34M | $467.02M |
| Gross Profit Ratio | 67.71% | 41.57% | 73.97% | 75.21% | 78.02% |
| Research and Development Expenses | $- | $- | $-0 | $-0 | $0 |
| General and Administrative Expenses | $50.07M | $47.47M | $39.57M | $34.67M | $32.76M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $50.07M | $47.47M | $39.57M | $34.67M | $32.76M |
| Other Expenses | $169.05M | $- | $187.92M | $182.93M | $178.59M |
| Operating Expenses | $219.12M | $42.45M | $227.50M | $217.59M | $211.35M |
| Cost and Expenses | $446.21M | $420.78M | $390.11M | $358.80M | $342.90M |
| Interest Income | $- | $- | $105.57M | $98.65M | $100.52M |
| Interest Expense | $115.27M | $112.96M | $105.47M | $98.63M | $100.42M |
| Depreciation and Amortization | $169.62M | $183.09M | $375.43M | $358.70M | $370.42M |
| EBITDA | $412.61M | $311.81M | $323.35M | $166.21M | $417.96M |
| EBITDA Ratio | 58.67% | 48.15% | 51.75% | 29.18% | 69.83% |
| Operating Income | $257.03M | $221.52M | $135.57M | $19.04M | $241.22M |
| Operating Income Ratio | 36.55% | 34.21% | 21.70% | 3.34% | 40.30% |
| Total Other Income Expenses Net | $-129.31M | $-205.76M | $-311.06M | $-322.16M | $-118.79M |
| Income Before Tax | $127.72M | $15.76M | $-76.36M | $-111.41M | $139.13M |
| Income Before Tax Ratio | 18.16% | 2.43% | -12.22% | -19.56% | 23.24% |
| Income Tax Expense | $1.00M | $2.00M | $1.24M | $1.84M | $710.00K |
| Net Income | $126.71M | $13.76M | $-77.61M | $-113.26M | $138.42M |
| Net Income Ratio | 18.02% | 2.12% | -12.42% | -19.89% | 23.12% |
| EPS | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 |
| EPS Diluted | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 |
| Weighted Average Shares Outstanding | 233.50M | 231.20M | 230.95M | 219.07M | 206.22M |
| Weighted Average Shares Outstanding Diluted | 236.05M | 232.79M | 230.95M | 219.07M | 207.25M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $182.35M | $178.00M | $178.53M | $172.20M | $164.38M | $161.63M | $161.17M | $161.32M | $164.99M | $140.76M | $155.96M | $163.10M | $135.66M | $128.59M | $152.93M | $152.37M | $152.05M | $143.25M | $153.92M | $149.35M |
| Cost of Revenue | $59.84M | $48.49M | $96.43M | $96.91M | $92.75M | $48.83M | $48.73M | $47.80M | $43.80M | $41.83M | $38.88M | $38.12M | $37.38M | $35.84M | $33.90M | $34.08M | $33.10M | $32.99M | $33.30M | $32.16M |
| Gross Profit | $122.51M | $129.51M | $82.10M | $75.29M | $71.63M | $112.80M | $112.43M | $113.52M | $121.19M | $98.94M | $117.08M | $124.99M | $98.27M | $92.75M | $119.03M | $118.28M | $118.96M | $110.26M | $120.62M | $117.18M |
| Gross Profit Ratio | 67.18% | 72.76% | 45.98% | 43.72% | 43.57% | 69.79% | 69.76% | 70.37% | 73.46% | 70.29% | 75.07% | 76.63% | 72.44% | 72.13% | 77.83% | 77.63% | 78.23% | 76.97% | 78.36% | 78.46% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $13.03M | $12.40M | $12.74M | $11.89M | $16.68M | $10.76M | $9.53M | $10.50M | $30.93M | $9.68M | $8.65M | $10.40M | $34.67M | $8.68M | $8.81M | $8.94M | $32.76M | $7.22M | $8.67M | $8.76M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $-20.07M | $- | $- | $- | $-26.43M | $- | $- | $- | $-24.65M | $- | $- | $- |
| Selling General and Administrative Expenses | $13.03M | $12.40M | $12.74M | $11.89M | $16.68M | $10.76M | $9.53M | $10.50M | $10.85M | $9.68M | $8.65M | $10.40M | $8.24M | $8.68M | $8.81M | $8.94M | $8.11M | $7.22M | $8.67M | $8.76M |
| Other Expenses | $42.18M | $- | $78.00K | $-14.65M | $-1.69M | $2.23M | $-9.96M | $52.62M | $50.08M | $994.00K | $44.90M | $45.73M | $-13.00K | $277.00K | $-24.00K | $133.00K | $-154.00K | $115.00K | $-66.00K | $2.26M |
| Operating Expenses | $55.22M | $12.40M | $54.26M | $14.65M | $1.69M | $54.33M | $54.10M | $63.12M | $60.93M | $56.89M | $53.55M | $56.13M | $55.36M | $53.70M | $53.19M | $55.34M | $53.41M | $51.34M | $53.00M | $53.60M |
| Cost and Expenses | $115.05M | $60.89M | $108.91M | $111.56M | $94.44M | $103.16M | $102.84M | $110.93M | $104.73M | $98.71M | $92.43M | $94.24M | $92.75M | $89.54M | $87.09M | $89.42M | $86.51M | $84.33M | $86.31M | $85.76M |
| Interest Income | $- | $- | $- | $- | $15.60M | $28.16M | $28.33M | $28.54M | $28.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $28.08M | $29.47M | $29.31M | $28.41M | $43.54M | $28.16M | $28.33M | $28.54M | $27.90M | $27.07M | $25.53M | $24.97M | $25.68M | $24.24M | $24.27M | $24.44M | $24.52M | $24.90M | $25.29M | $25.70M |
| Depreciation and Amortization | $42.31M | $42.72M | $41.68M | $42.91M | $42.88M | $43.24M | $44.14M | $52.83M | $49.93M | $47.43M | $45.17M | $45.26M | $45.08M | $45.05M | $44.49M | $44.38M | $44.16M | $44.21M | $44.20M | $44.17M |
| EBITDA | $117.47M | $101.71M | $108.81M | $100.41M | $112.82M | $101.07M | $101.82M | $102.73M | $-36.11M | $-3.22M | $104.01M | $111.39M | $46.93M | $244.18M | $-59.46M | $102.31M | $114.17M | $107.10M | $99.58M | $106.19M |
| EBITDA Ratio | 64.42% | 57.14% | 60.95% | 58.31% | 68.63% | 62.53% | 63.18% | 63.68% | -21.89% | -2.28% | 66.69% | 68.29% | 34.60% | 189.89% | -38.88% | 67.15% | 75.09% | 74.76% | 64.70% | 71.10% |
| Operating Income | $67.29M | $64.52M | $69.62M | $60.64M | $69.94M | $148.85M | $57.67M | $49.90M | $-28.06M | $37.67M | $58.84M | $66.13M | $1.85M | $39.05M | $65.84M | $62.95M | $65.55M | $58.92M | $67.61M | $63.59M |
| Operating Income Ratio | 36.90% | 36.25% | 38.99% | 35.21% | 42.55% | 92.09% | 35.79% | 30.93% | -17.01% | 26.76% | 37.73% | 40.54% | 1.37% | 30.37% | 43.05% | 41.31% | 43.11% | 41.13% | 43.93% | 42.58% |
| Total Other Income Expenses Net | $-20.22M | $-35.00M | $-42.72M | $-33.93M | $-52.29M | $-73.12M | $-36.16M | $-58.32M | $-83.92M | $-83.09M | $-43.94M | $-25.37M | $-25.68M | $-21.68M | $-197.89M | $-23.79M | $-29.06M | $-26.57M | $-25.32M | $-25.76M |
| Income Before Tax | $47.08M | $29.52M | $24.41M | $26.71M | $17.65M | $-14.65M | $21.51M | $-8.76M | $-84.82M | $-49.48M | $17.06M | $40.89M | $-23.82M | $10.31M | $-132.05M | $34.15M | $36.49M | $36.32M | $30.06M | $36.26M |
| Income Before Tax Ratio | 25.82% | 16.59% | 13.67% | 15.51% | 10.74% | -9.06% | 13.35% | -5.43% | -51.41% | -35.15% | 10.94% | 25.07% | -17.56% | 8.02% | -86.35% | 22.41% | 24.00% | 25.36% | 19.53% | 24.28% |
| Income Tax Expense | $380.00K | $-265.00K | $437.00K | $453.00K | $493.00K | $455.00K | $326.00K | $728.00K | $124.00K | $579.00K | $255.00K | $284.00K | $531.00K | $92.00K | $522.00K | $700.00K | $-627.00K | $-138.00K | $433.00K | $1.04M |
| Net Income | $46.70M | $29.79M | $23.98M | $26.25M | $17.16M | $-15.10M | $21.19M | $-9.49M | $-84.95M | $-50.06M | $16.80M | $40.60M | $-24.35M | $10.22M | $-132.57M | $33.45M | $37.12M | $36.46M | $29.62M | $35.22M |
| Net Income Ratio | 25.61% | 16.73% | 13.43% | 15.25% | 10.44% | -9.34% | 13.15% | -5.88% | -51.49% | -35.57% | 10.78% | 24.89% | -17.95% | 7.95% | -86.69% | 21.95% | 24.41% | 25.45% | 19.25% | 23.58% |
| EPS | $0.20 | $0.13 | $0.10 | $0.11 | $0.07 | $-0.07 | $0.09 | $-0.04 | $-0.37 | $-0.22 | $0.07 | $0.18 | $-0.11 | $0.05 | $-0.62 | $0.16 | $0.18 | $0.18 | $0.14 | $0.17 |
| EPS Diluted | $0.19 | $0.13 | $0.10 | $0.11 | $0.07 | $-0.07 | $0.09 | $-0.04 | $-0.37 | $-0.22 | $0.07 | $0.18 | $-0.11 | $0.05 | $-0.61 | $0.16 | $0.18 | $0.18 | $0.14 | $0.17 |
| Weighted Average Shares Outstanding | 236.60M | 234.29M | 231.62M | 231.45M | 231.22M | 231.22M | 231.20M | 231.16M | 230.99M | 230.98M | 230.97M | 230.86M | 219.31M | 220.87M | 214.42M | 211.45M | 208.10M | 205.79M | 205.59M | 205.40M |
| Weighted Average Shares Outstanding Diluted | 239.64M | 237.04M | 233.75M | 233.37M | 233.20M | 231.22M | 232.24M | 231.16M | 230.99M | 230.98M | 231.68M | 231.56M | 227.52M | 222.06M | 216.26M | 212.62M | 209.32M | 206.73M | 206.22M | 206.01M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $60.47M | $41.28M | $49.31M | $112.00M | $59.08M |
| Short Term Investments | $- | $18.92M | $411.40M | $3.33M | $12.80M |
| Cash and Short Term Investments | $60.47M | $41.28M | $49.31M | $112.00M | $59.08M |
| Net Receivables | $513.22M | $103.29M | $147.91M | $480.14M | $219.54M |
| Inventory | $- | $- | $411.40M | $119.78M | $71.97M |
| Other Current Assets | $5.87M | $68.13M | $-411.40M | $3.89M | $6.45M |
| Total Current Assets | $579.56M | $212.70M | $613.24M | $653.08M | $329.01M |
| Property Plant Equipment Net | $- | $- | $4.96B | $5.16B | $5.29B |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $27.46M | $30.90M | $40.13M | $54.06M | $82.80M |
| Goodwill and Intangible Assets | $27.46M | $30.90M | $40.13M | $54.06M | $82.80M |
| Long Term Investments | $182.92M | $194.69M | $134.96M | $96.68M | $288.76M |
| Tax Assets | $- | $- | $-4.96B | $-5.16B | $-5.29B |
| Other Non-Current Assets | $4.51B | $4.62B | $4.96B | $5.16B | $5.29B |
| Total Non-Current Assets | $4.72B | $4.84B | $5.13B | $5.31B | $5.66B |
| Other Assets | $- | $330.60M | $- | $- | $- |
| Total Assets | $5.30B | $5.39B | $5.75B | $5.97B | $5.99B |
| Account Payables | $- | $73.79M | $142.26M | $142.99M | $72.16M |
| Short Term Debt | $1.76B | $96.46M | $196.98M | $17.48M | $18.42M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $-72.16M |
| Other Current Liabilities | $- | $61.16M | $-196.98M | $1.62B | $1.22B |
| Total Current Liabilities | $1.76B | $231.41M | $142.26M | $142.99M | $146.28M |
| Long Term Debt | $26.85M | $2.35B | $2.55B | $2.43B | $2.41B |
| Deferred Revenue Non-Current | $- | $- | $2.69B | $2.59B | $2.58B |
| Deferred Tax Liabilities Non-Current | $- | $- | $42.24M | $49.71M | $57.73M |
| Other Non-Current Liabilities | $772.67M | $- | $-1.63B | $-1.62B | $-1.14B |
| Total Non-Current Liabilities | $799.52M | $2.35B | $2.55B | $2.44B | $2.43B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $2.56B | $2.58B | $2.69B | $2.59B | $2.58B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $2.38M | $2.31M | $2.31M | $2.30M | $2.11M |
| Retained Earnings | $- | $-1.72B | $-1.45B | $-1.10B | $-716.20M |
| Accumulated Other Comprehensive Income Loss | $20.94M | $963.00K | $19.06M | $-10.02M | $-39.91M |
| Other Total Stockholders Equity | $2.72B | $4.52B | $4.49B | $4.48B | $4.16B |
| Total Stockholders Equity | $2.74B | $2.80B | $3.06B | $3.38B | $3.41B |
| Total Equity | $2.74B | $2.80B | $5.55B | $5.71B | $5.77B |
| Total Liabilities and Stockholders Equity | $5.30B | $5.39B | $5.75B | $5.97B | $5.99B |
| Minority Interest | $- | $- | $2.50B | $2.33B | $2.36B |
| Total Liabilities and Total Equity | $5.30B | $5.39B | $5.75B | $5.97B | $5.99B |
| Total Investments | $182.92M | $213.61M | $597.43M | $96.68M | $288.76M |
| Total Debt | $1.76B | $2.45B | $2.70B | $2.39B | $2.37B |
| Net Debt | $1.70B | $2.41B | $2.65B | $2.28B | $2.31B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $60.47M | $63.00M | $42.31M | $65.93M | $46.72M | $33.26M | $27.23M | $33.53M | $49.31M | $26.29M | $67.15M | $24.84M | $112.00M | $546.34M | $69.35M | $24.88M | $59.08M | $35.03M | $28.25M | $54.05M |
| Short Term Investments | $- | $- | $-57.33M | $27.14M | $18.92M | $39.33M | $31.12M | $19.82M | $411.40M | $22.76M | $395.34M | $- | $57.05M | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $60.47M | $63.00M | $42.31M | $65.93M | $46.72M | $33.26M | $27.23M | $33.53M | $49.31M | $26.29M | $67.15M | $24.84M | $112.00M | $546.34M | $69.35M | $24.88M | $59.08M | $35.03M | $28.25M | $54.05M |
| Net Receivables | $513.22M | $121.46M | $527.82M | $511.05M | $496.58M | $513.26M | $507.93M | $489.10M | $147.91M | $490.21M | $516.95M | $496.59M | $480.14M | $191.81M | $235.85M | $244.84M | $219.54M | $221.01M | $217.47M | $232.22M |
| Inventory | $- | $- | $335.19M | $59.93M | $46.72M | $44.46M | $37.53M | $43.84M | $411.40M | $-22.76M | $395.34M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Current Assets | $5.87M | $5.97M | $5.91M | $6.00M | $- | $5.60M | $5.15M | $5.15M | $-411.40M | $4.86M | $4.37M | $4.44M | $3.89M | $5.08M | $4.59M | $4.61M | $6.45M | $6.82M | $8.55M | $8.38M |
| Total Current Assets | $579.56M | $184.46M | $570.13M | $576.98M | $543.30M | $609.04M | $540.30M | $580.50M | $613.24M | $521.36M | $588.47M | $525.87M | $653.08M | $743.23M | $309.78M | $274.33M | $329.01M | $262.86M | $254.27M | $294.65M |
| Property Plant Equipment Net | $- | $- | $4.57B | $4.59B | $4.63B | $4.60B | $4.75B | $4.80B | $4.96B | $5.02B | $5.05B | $5.16B | $5.16B | $5.23B | $5.27B | $5.28B | $5.29B | $5.31B | $5.36B | $5.36B |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $27.46M | $28.79M | $27.72M | $28.30M | $30.90M | $32.75M | $35.99M | $39.37M | $40.13M | $48.30M | $49.84M | $52.88M | $54.06M | $76.43M | $79.65M | $81.45M | $82.80M | $85.94M | $93.50M | $96.76M |
| Goodwill and Intangible Assets | $27.46M | $28.79M | $27.72M | $28.30M | $30.90M | $32.75M | $35.99M | $39.37M | $40.13M | $48.30M | $49.84M | $52.88M | $54.06M | $76.43M | $79.65M | $81.45M | $82.80M | $85.94M | $93.50M | $96.76M |
| Long Term Investments | $182.92M | $- | $187.10M | $218.98M | $213.61M | $135.75M | $196.14M | $139.40M | $134.96M | $256.36M | $277.99M | $150.13M | $96.68M | $161.21M | $163.26M | $328.61M | $288.76M | $336.55M | $317.26M | $337.73M |
| Tax Assets | $- | $- | $37.18M | $-4.59B | $-4.63B | $-4.60B | $-4.75B | $-4.80B | $-4.96B | $-408.62M | $-5.05B | $-5.16B | $-5.16B | $-5.23B | $-5.27B | $-5.28B | $-5.29B | $-5.31B | $-5.36B | $-5.36B |
| Other Non-Current Assets | $4.51B | $- | $-37.18M | $4.55B | $4.60B | $4.60B | $4.75B | $4.80B | $4.96B | $- | $5.05B | $5.16B | $5.16B | $5.23B | $5.27B | $5.28B | $5.29B | $5.31B | $5.36B | $5.36B |
| Total Non-Current Assets | $4.72B | $28.79M | $4.78B | $4.80B | $4.84B | $4.77B | $4.98B | $4.98B | $5.13B | $5.32B | $5.37B | $5.36B | $5.31B | $5.47B | $5.51B | $5.69B | $5.66B | $5.73B | $5.77B | $5.80B |
| Other Assets | $- | $5.15B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $5.30B | $5.37B | $5.35B | $5.37B | $5.39B | $5.38B | $5.52B | $5.56B | $5.75B | $5.84B | $5.96B | $5.88B | $5.97B | $6.21B | $5.82B | $5.96B | $5.99B | $5.99B | $6.02B | $6.09B |
| Account Payables | $- | $- | $112.83M | $59.04M | $73.79M | $78.34M | $121.86M | $94.00M | $142.26M | $109.32M | $117.68M | $118.30M | $142.99M | $- | $- | $123.50M | $- | $143.74M | $143.32M | $150.93M |
| Short Term Debt | $1.76B | $- | $1.02M | $1.53M | $196.63M | $32.62M | $996.00K | $79.56M | $196.98M | $- | $- | $- | $17.48M | $16.28M | $17.42M | $17.90M | $18.42M | $655.00K | $1.61M | $2.39M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $129.34M | $-59.04M | $-73.79M | $-78.34M | $- | $-94.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Current Liabilities | $- | $1.76B | $1.65B | $42.30M | $1.50B | $1.66B | $1.65B | $1.60B | $-196.98M | $35.90M | $- | $- | $1.62B | $2.07B | $1.28B | $1.16B | $1.29B | $1.16B | $1.17B | $1.16B |
| Total Current Liabilities | $1.76B | $1.76B | $112.83M | $258.89M | $231.41M | $160.66M | $121.86M | $222.56M | $142.26M | $145.22M | $117.68M | $118.30M | $142.99M | $126.83M | $119.42M | $123.50M | $146.28M | $143.74M | $143.32M | $150.93M |
| Long Term Debt | $26.85M | $2.50B | $2.48B | $2.49B | $2.25B | $2.35B | $2.46B | $2.36B | $2.35B | $2.49B | $2.53B | $2.41B | $2.44B | $2.75B | $2.32B | $2.34B | $2.43B | $2.48B | $2.52B | $2.55B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $772.67M | $513.00K | $1.02M | $11.43M | $102.21M | $- | $996.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Non-Current Liabilities | $799.52M | $2.50B | $2.48B | $2.35B | $2.35B | $2.35B | $2.46B | $2.36B | $2.55B | $2.49B | $2.53B | $2.41B | $2.44B | $2.75B | $2.32B | $2.34B | $2.43B | $2.48B | $2.52B | $2.55B |
| Other Liabilities | $- | $-1.64B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $2.56B | $2.62B | $2.59B | $2.61B | $2.58B | $2.51B | $2.58B | $2.58B | $2.69B | $2.64B | $2.64B | $2.52B | $2.59B | $2.88B | $2.44B | $2.46B | $2.58B | $2.63B | $2.66B | $2.70B |
| Preferred Stock | $- | $- | $32.35M | $29.42M | $20.47M | $1.67B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $2.38M | $2.37M | $2.34M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.31M | $2.30M | $2.21M | $2.21M | $2.16M | $2.11M | $2.07M | $2.06M | $2.06M |
| Retained Earnings | $- | $-1.85B | $-1.81B | $-1.76B | $-1.72B | $-1.67B | $-1.58B | $-1.53B | $-1.45B | $-1.30B | $-1.18B | $-1.12B | $-1.10B | $-1.00B | $-944.50M | $-746.52M | $-716.20M | $-689.83M | $-663.90M | $-631.25M |
| Accumulated Other Comprehensive Income Loss | $20.94M | $16.94M | $-1.21M | $-535.00K | $963.00K | $39.67M | $32.24M | $17.44M | $19.06M | $18.52M | $10.14M | $1.67M | $-10.02M | $-16.14M | $-16.17M | $-6.37M | $-39.91M | $-49.17M | $-55.64M | $-51.37M |
| Other Total Stockholders Equity | $2.72B | $4.57B | $6.34B | $6.26B | $6.21B | $4.49B | $4.49B | $4.49B | $5.94B | $4.48B | $4.48B | $4.48B | $4.48B | $4.34B | $4.34B | $4.25B | $4.16B | $4.10B | $4.08B | $4.08B |
| Total Stockholders Equity | $2.74B | $2.74B | $2.76B | $2.77B | $2.80B | $2.87B | $2.94B | $2.98B | $3.06B | $3.21B | $3.32B | $3.36B | $3.38B | $3.33B | $3.38B | $3.50B | $3.41B | $3.36B | $3.36B | $3.40B |
| Total Equity | $2.74B | $2.74B | $2.76B | $2.77B | $2.80B | $2.87B | $2.94B | $2.98B | $3.06B | $3.21B | $3.32B | $3.36B | $3.38B | $3.33B | $3.38B | $3.50B | $3.41B | $3.36B | $3.36B | $3.40B |
| Total Liabilities and Stockholders Equity | $5.30B | $5.37B | $5.35B | $5.37B | $5.39B | $5.38B | $5.52B | $5.56B | $5.75B | $5.84B | $5.96B | $5.88B | $5.97B | $6.21B | $5.82B | $5.96B | $5.99B | $5.99B | $6.02B | $6.09B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $5.30B | $5.37B | $5.35B | $5.37B | $5.39B | $5.38B | $5.52B | $5.56B | $5.75B | $5.84B | $5.96B | $5.88B | $5.97B | $6.21B | $5.82B | $5.96B | $5.99B | $5.99B | $6.02B | $6.09B |
| Total Investments | $182.92M | $- | $129.77M | $218.98M | $213.61M | $135.75M | $196.14M | $139.40M | $597.43M | $279.12M | $673.34M | $150.13M | $153.74M | $161.21M | $163.26M | $328.61M | $288.76M | $336.55M | $317.26M | $337.73M |
| Total Debt | $1.76B | $2.50B | $2.48B | $2.49B | $2.45B | $2.35B | $2.42B | $2.40B | $2.70B | $2.45B | $2.48B | $2.36B | $2.39B | $2.70B | $2.27B | $2.28B | $2.37B | $2.42B | $2.46B | $2.48B |
| Net Debt | $1.70B | $2.44B | $2.43B | $2.43B | $2.40B | $2.32B | $2.39B | $2.36B | $2.65B | $2.42B | $2.41B | $2.33B | $2.28B | $2.16B | $2.20B | $2.26B | $2.31B | $2.39B | $2.43B | $2.43B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $126.71M | $13.76M | $-77.61M | $-113.26M | $138.42M |
| Depreciation and Amortization | $169.62M | $183.09M | $187.78M | $178.99M | $176.74M |
| Deferred Income Tax | $- | $- | $- | $227.84M | $32.92M |
| Stock Based Compensation | $8.99M | $7.92M | $7.45M | $7.91M | $7.91M |
| Change in Working Capital | $- | $-2.73M | $-19.69M | $22.70M | $-2.74M |
| Accounts Receivables | $-15.46M | $-11.08M | $-6.44M | $8.22M | $-6.40M |
| Inventory | $- | $11.08M | $6.44M | $-8.22M | $6.40M |
| Accounts Payables | $-7.09M | $8.34M | $-13.25M | $14.48M | $3.66M |
| Other Working Capital | $- | $-11.08M | $-6.44M | $8.22M | $-6.40M |
| Other Non Cash Items | $5.22M | $98.55M | $217.80M | $32.20M | $1.61M |
| Net Cash Provided by Operating Activities | $310.54M | $300.57M | $315.73M | $356.39M | $354.85M |
| Investments in Property Plant and Equipment | $- | $- | $- | $-33.61M | $-105.59M |
| Acquisitions Net | $- | $-5.24M | $-142.91M | $-7.77M | $-16.65M |
| Purchases of Investments | $- | $-11.02M | $-8.02M | $-9.06M | $-20.07M |
| Sales Maturities of Investments | $- | $- | $5.38M | $1.29M | $3.42M |
| Other Investing Activities | $-109.00M | $119.39M | $-70.69M | $-287.05M | $2.44M |
| Net Cash Used for Investing Activities | $-109.00M | $103.13M | $-216.25M | $-336.20M | $-136.45M |
| Debt Repayment | $12.56M | $-94.13M | $122.78M | $23.86M | $-3.07M |
| Common Stock Issued | $86.12M | $- | $- | $308.71M | $80.09M |
| Common Stock Repurchased | $- | $-2.68M | $-4.81M | $- | $- |
| Dividends Paid | $-280.15M | $-277.45M | $-277.16M | $-262.92M | $-278.30M |
| Other Financing Activities | $-94.00K | $-36.04M | $-2.52M | $-39.51M | $-830.00K |
| Net Cash Used Provided by Financing Activities | $-181.56M | $-410.30M | $-161.71M | $30.14M | $-202.11M |
| Effect of Forex Changes on Cash | $-359.00K | $-614.00K | $268.00K | $29.00K | $88.00K |
| Net Change in Cash | $19.62M | $-7.21M | $-61.95M | $50.36M | $16.38M |
| Cash at End of Period | $66.34M | $46.72M | $53.93M | $115.89M | $65.52M |
| Cash at Beginning of Period | $46.72M | $53.93M | $115.89M | $65.52M | $49.14M |
| Operating Cash Flow | $310.54M | $300.57M | $315.73M | $356.39M | $354.85M |
| Capital Expenditure | $- | $- | $- | $-33.61M | $-105.59M |
| Free Cash Flow | $310.54M | $300.57M | $315.73M | $322.78M | $249.26M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $46.70M | $29.79M | $23.98M | $26.25M | $17.16M | $-15.10M | $21.19M | $-9.49M | $-84.95M | $-50.06M | $16.80M | $40.60M | $-24.35M | $10.22M | $-132.57M | $33.45M | $37.12M | $36.46M | $29.62M | $35.22M |
| Depreciation and Amortization | $42.31M | $42.72M | $41.68M | $42.91M | $42.88M | $43.24M | $44.14M | $52.83M | $49.93M | $47.43M | $45.17M | $45.26M | $45.08M | $45.05M | $44.49M | $44.38M | $44.16M | $44.21M | $44.20M | $44.17M |
| Deferred Income Tax | $- | $- | $- | $- | $-82.87M | $48.11M | $9.66M | $- | $- | $- | $- | $- | $43.09M | $4.75M | $173.49M | $6.51M | $7.00M | $1.96M | $15.37M | $8.59M |
| Stock Based Compensation | $2.54M | $2.59M | $1.34M | $2.52M | $2.45M | $2.23M | $1.00M | $2.23M | $2.09M | $2.12M | $794.00K | $2.46M | $927.00K | $2.43M | $2.27M | $2.29M | $2.26M | $916.00K | $2.38M | $2.36M |
| Change in Working Capital | $-6.75M | $29.69M | $-2.05M | $-27.64M | $4.91M | $6.65M | $-5.67M | $-8.62M | $-16.22M | $28.50M | $-5.54M | $-26.43M | $15.04M | $21.80M | $-273.00K | $-13.87M | $3.38M | $3.94M | $6.77M | $-16.82M |
| Accounts Receivables | $- | $-4.88M | $-2.42M | $-6.29M | $-418.00K | $-4.38M | $-3.50M | $-2.78M | $-812.00K | $443.00K | $-617.00K | $-5.46M | $-4.84M | $15.42M | $512.00K | $-2.87M | $-2.88M | $-2.15M | $5.52M | $-6.89M |
| Inventory | $- | $- | $- | $- | $418.00K | $-11.03M | $2.18M | $- | $- | $- | $4.93M | $20.97M | $- | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $18.77M | $364.00K | $-21.35M | $5.33M | $11.03M | $-2.18M | $-5.84M | $-13.25M | $- | $-4.93M | $-20.97M | $19.88M | $6.37M | $-785.00K | $-10.99M | $6.25M | $6.09M | $1.25M | $-9.93M |
| Other Working Capital | $-6.75M | $15.80M | $-2.42M | $-6.29M | $-418.00K | $11.03M | $-2.18M | $8.62M | $-2.16M | $- | $-4.93M | $-20.97M | $-4.84M | $15.42M | $512.00K | $-2.87M | $- | $- | $- | $- |
| Other Non Cash Items | $-4.83M | $-7.13M | $99.52M | $118.44M | $94.21M | $-1.92M | $10.00K | $31.34M | $116.75M | $15.24M | $19.34M | $1.23M | $18.14M | $21.95M | $-3.67M | $-4.23M | $-4.51M | $9.37M | $-4.55M | $1.31M |
| Net Cash Provided by Operating Activities | $79.97M | $97.65M | $80.13M | $52.80M | $78.74M | $83.22M | $70.33M | $68.29M | $67.59M | $108.46M | $76.57M | $63.11M | $97.93M | $106.19M | $83.73M | $68.53M | $89.40M | $96.85M | $93.79M | $74.82M |
| Investments in Property Plant and Equipment | $- | $- | $- | $- | $5.27M | $-80.63M | $-21.26M | $- | $- | $- | $128.74M | $-729.00K | $39.25M | $-277.00K | $- | $- | $-23.60M | $- | $- | $- |
| Acquisitions Net | $-5.86M | $344.00K | $-156.00K | $-188.00K | $-5.27M | $4.83M | $-1.43M | $-4.80M | $-14.89M | $-12.00K | $-128.74M | $729.00K | $-4.30M | $-589.00K | $-3.18M | $301.00K | $16.66M | $-19.72M | $5.00K | $3.06M |
| Purchases of Investments | $-303.00K | $-1.51M | $-68.37M | $-14.23M | $-62.21M | $-339.00K | $-4.29M | $-6.38M | $-2.21M | $-823.00K | $-916.00K | $-4.07M | $-4.91M | $-759.00K | $-47.75M | $-39.49M | $-10.00K | $-20.06M | $- | $- |
| Sales Maturities of Investments | $- | $- | $11.07M | $1.01M | $-24.86M | $80.63M | $21.26M | $1.43M | $1.20M | $2.84M | $604.00K | $729.00K | $609.00K | $170.00K | $212.00K | $301.00K | $20.00K | $335.00K | $5.00K | $3.06M |
| Other Investing Activities | $24.73M | $-55.87M | $-18.85M | $289.00K | $25.29M | $55.44M | $-2.47M | $122.92M | $-15.26M | $-4.08M | $-90.55M | $-33.90M | $-289.48M | $1.30M | $-38.88M | $-35.96M | $998.00K | $-12.16M | $-29.15M | $-75.94M |
| Net Cash Used for Investing Activities | $18.56M | $-57.03M | $-57.31M | $-13.22M | $-61.78M | $59.93M | $-8.19M | $113.17M | $-31.16M | $-56.99M | $-90.86M | $-37.24M | $-258.83M | $-158.00K | $-41.85M | $-35.36M | $-5.93M | $-31.55M | $-29.14M | $-69.82M |
| Debt Repayment | $-44.73M | $21.37M | $-15.97M | $51.90M | $60.49M | $-66.98M | $19.09M | $-106.75M | $56.21M | $-19.23M | $125.30M | $-39.50M | $-310.48M | $445.78M | $-17.74M | $-93.71M | $-56.68M | $-17.82M | $-28.80M | $100.12M |
| Common Stock Issued | $- | $34.96M | $- | $- | $-1.18M | $- | $- | $- | $- | $- | $- | $- | $136.53M | $-510.00K | $85.04M | $87.65M | $59.13M | $19.10M | $-70.00K | $1.93M |
| Common Stock Repurchased | $- | $- | $- | $-2.61M | $- | $- | $-306.00K | $-1.85M | $-416.00K | $-591.00K | $-55.00K | $-3.75M | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $-70.98M | $-70.28M | $-69.45M | $-69.44M | $-69.37M | $-69.37M | $-69.36M | $-69.35M | $-69.30M | $-69.30M | $-69.29M | $-69.28M | $-68.61M | $-66.26M | $-64.83M | $-63.22M | $-62.55M | $-61.68M | $-61.68M | $-92.39M |
| Other Financing Activities | $-14.00K | $- | $- | $-80.00K | $- | $-7.00K | $-17.90M | $-18.13M | $-14.00K | $-2.50M | $- | $- | $-32.07M | $-7.44M | $-7.00K | $- | $-11.00K | $- | $- | $-715.00K |
| Net Cash Used Provided by Financing Activities | $-100.96M | $-13.96M | $-46.41M | $-20.23M | $-9.36M | $-136.39M | $-68.47M | $-196.07M | $-13.52M | $-91.62M | $55.95M | $-112.52M | $-274.63M | $371.57M | $2.47M | $-69.28M | $-60.11M | $-60.40M | $-90.55M | $8.95M |
| Effect of Forex Changes on Cash | $-201.00K | $2.00K | $-29.00K | $-131.00K | $266.00K | $-272.00K | $33.00K | $-641.00K | $-124.00K | $-227.00K | $579.00K | $40.00K | $-5.00K | $-125.00K | $94.00K | $65.00K | $318.00K | $146.00K | $284.00K | $-660.00K |
| Net Change in Cash | $-2.64M | $26.67M | $-23.62M | $19.21M | $7.86M | $6.48M | $-6.30M | $-15.25M | $22.78M | $-40.37M | $42.24M | $-86.61M | $-435.53M | $477.48M | $44.45M | $-36.04M | $23.67M | $5.04M | $-25.62M | $13.28M |
| Cash at End of Period | $66.34M | $68.98M | $42.31M | $65.93M | $46.72M | $38.86M | $32.38M | $38.68M | $53.93M | $31.15M | $71.52M | $29.28M | $115.89M | $551.42M | $73.94M | $29.49M | $65.52M | $41.85M | $36.80M | $62.43M |
| Cash at Beginning of Period | $68.98M | $42.31M | $65.93M | $46.72M | $38.86M | $32.38M | $38.68M | $53.93M | $31.15M | $71.52M | $29.28M | $115.89M | $551.42M | $73.94M | $29.49M | $65.52M | $41.85M | $36.80M | $62.43M | $49.14M |
| Operating Cash Flow | $79.97M | $97.65M | $80.13M | $52.80M | $78.74M | $83.22M | $70.33M | $68.29M | $67.59M | $108.46M | $76.57M | $63.11M | $97.93M | $106.19M | $83.73M | $68.53M | $89.40M | $96.85M | $93.79M | $74.82M |
| Capital Expenditure | $- | $- | $- | $- | $5.27M | $-80.63M | $-21.26M | $- | $- | $- | $128.74M | $-729.00K | $39.25M | $-277.00K | $- | $- | $-23.60M | $- | $- | $- |
| Free Cash Flow | $79.97M | $97.65M | $80.13M | $52.80M | $84.00M | $2.59M | $49.07M | $68.29M | $67.59M | $108.46M | $205.31M | $62.38M | $137.18M | $105.92M | $83.73M | $68.53M | $65.80M | $96.85M | $93.79M | $74.82M |
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
$17.51
Stock Price
$4.17B
Market Cap
50
Employees
Irvine, CA
Location
Revenue (FY 2024)
$703.24M
8.6% YoY
Net Income (FY 2024)
$126.71M
821.1% YoY
EPS (FY 2024)
$0.54
813.7% YoY
Free Cash Flow (FY 2024)
$310.54M
3.3% YoY
Profitability
Gross Margin
67.7%
Net Margin
18.0%
ROE
4.6%
ROA
2.4%
Valuation
P/E Ratio
31.92
P/S Ratio
5.75
EV/EBITDA
13.93
Market Cap
$4.17B
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$310.54M
3.3% YoY
Free Cash Flow
$310.54M
3.3% YoY
Balance Sheet Summary
Total Assets
$5.30B
-1.5% YoY
Total Debt
$1.76B
27.9% YoY
Shareholder Equity
$2.74B
-3.1% YoY
Dividend Overview
$0.30
Latest Dividend
%
Dividend Yield
%
Payout Ratio
Recent Dividend History
| Date | Amount | Type |
|---|---|---|
| 2025-02-14 | $0.30 | February 14, 25 |
| 2024-11-15 | $0.30 | November 15, 24 |
| 2024-08-19 | $0.30 | August 19, 24 |
| 2024-05-17 | $0.30 | May 17, 24 |
| 2024-02-12 | $0.30 | February 12, 24 |
| 2023-11-16 | $0.30 | November 16, 23 |
| 2023-08-16 | $0.30 | August 16, 23 |
| 2023-05-15 | $0.30 | May 15, 23 |
| 2023-02-10 | $0.30 | February 10, 23 |
| 2022-11-16 | $0.30 | November 16, 22 |
Sabra Health Care REIT Dividends
Explore Sabra Health Care REIT's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
6.93%
Dividend Payout Ratio
221.09%
Dividend Paid & Capex Coverage Ratio
1.11x
Sabra Health Care REIT Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.3 | $0.3 | February 14, 2025 | February 14, 2025 | February 28, 2025 | February 03, 2025 |
| $0.3 | $0.3 | November 15, 2024 | November 15, 2024 | November 29, 2024 | October 31, 2024 |
| $0.3 | $0.3 | August 19, 2024 | August 19, 2024 | August 30, 2024 | August 07, 2024 |
| $0.3 | $0.3 | May 17, 2024 | May 20, 2024 | May 31, 2024 | May 08, 2024 |
| $0.3 | $0.3 | February 12, 2024 | February 13, 2024 | February 29, 2024 | February 01, 2024 |
| $0.3 | $0.3 | November 16, 2023 | November 17, 2023 | November 30, 2023 | November 06, 2023 |
| $0.3 | $0.3 | August 16, 2023 | August 17, 2023 | August 31, 2023 | August 07, 2023 |
| $0.3 | $0.3 | May 15, 2023 | May 16, 2023 | May 31, 2023 | May 03, 2023 |
| $0.3 | $0.3 | February 10, 2023 | February 13, 2023 | February 28, 2023 | February 01, 2023 |
| $0.3 | $0.3 | November 16, 2022 | November 17, 2022 | November 30, 2022 | November 07, 2022 |
| $0.3 | $0.3 | August 16, 2022 | August 17, 2022 | August 31, 2022 | August 03, 2022 |
| $0.3 | $0.3 | May 13, 2022 | May 16, 2022 | May 31, 2022 | May 04, 2022 |
| $0.3 | $0.3 | February 10, 2022 | February 11, 2022 | February 28, 2022 | February 01, 2022 |
| $0.3 | $0.3 | November 15, 2021 | November 16, 2021 | November 30, 2021 | November 03, 2021 |
| $0.3 | $0.3 | August 16, 2021 | August 17, 2021 | August 31, 2021 | August 04, 2021 |
| $0.3 | $0.3 | May 14, 2021 | May 17, 2021 | May 28, 2021 | May 05, 2021 |
| $0.3 | $0.3 | February 11, 2021 | February 12, 2021 | February 26, 2021 | February 02, 2021 |
| $0.3 | $0.3 | November 13, 2020 | November 16, 2020 | November 30, 2020 | November 05, 2020 |
| $0.3 | $0.3 | August 14, 2020 | August 17, 2020 | August 31, 2020 | August 05, 2020 |
| $0.3 | $0.3 | May 15, 2020 | May 18, 2020 | May 29, 2020 | May 06, 2020 |
Sabra Health Care REIT News
Read the latest news about Sabra Health Care REIT, including recent articles, headlines, and updates.
Sabra Health Care REIT: 7% Yield And Aging Population Make It A Downturn-Ready Pick
Sabra Health Care REIT's strong fundamentals, 6.62% dividend yield, and low forward multiple make it an attractive investment amid tariff uncertainties and potential recession. The REIT's solid growth in FFO, AFFO, and revenue, driven by increased occupancy rates and NOI growth, highlights its resilience in a challenging economic environment. Sabra's well-positioned balance sheet, with robust liquidity and deleveraging efforts, ensures stability and growth potential, even during economic downturns.
Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number.
Embrace The Fear: 2 Safe-Havens To Take Shelter In During The Market Storm
Tariffs have caused market turmoil, but long-term investors should consider recession-resistant REITs like CareTrust and Agree Realty to limit downside. CareTrust REIT has strong fundamentals, a low-leveraged balance sheet, and a growing portfolio, making it a solid choice during economic uncertainty. Agree Realty offers a recession-resistant portfolio with investment-grade tenants, a monthly dividend, and a strong balance sheet, positioning it well for market volatility.
Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.
Sabra Health Care REIT: Come For Income, Stay For Growth
Sabra Health Care REIT, Inc. offers a 6.7% dividend yield, benefiting from strong fundamentals, favorable demographics, and a well-managed balance sheet. Management is guiding for AFFO growth, supported by rising occupancy, stable reimbursement rates, and a robust acquisition pipeline in skilled nursing. SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns.
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have little impact on skilled nursing facility REITs, and the current selloff presents a buying opportunity for CareTrust REIT. Single-family rental REITs face challenges from high home prices and mortgage rates, but offer quality rental homes and professional management.
Sabra Health Care REIT, Inc. (SBRA) Q4 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Company Participants Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO Conference Call Participants Farrell Granath - Bank of America John Kilichowski - Wells Fargo Michael Griffin - Citi Research Austin Wurschmidt - KeyBanc Capital Markets Georgi Dinkov - Mizuho Juan Sanabria - BMO Capital Markets Richard Anderson - Wedbush Alec Feygin - Baird Equity Research Michael Stroyeck - Green Street Aaron Hecht - JMP Securities Omotayo Okusanya - Deutsche Bank Operator Good day. My name is Aaron, and I will be your conference operator for today.
Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Beh.
Sabra Health Care REIT, Inc. Announces Leadership Promotions
TUSTIN, Calif.--(BUSINESS WIRE)-- #LEADERSHIP--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced three promotions within its leadership team. Lukas Hartwich has been promoted to Executive Vice President – Finance after previously serving as Senior Vice President – Finance. Since joining Sabra in October 2021, Mr. Hartwich has made notable contributions across the organization, including through his leadership of Sabra's financial planning and analysis, investor rela.
Gear Up for Sabra (SBRA) Q4 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Sabra (SBRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call; Declares Common Dividend
TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conferen.
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions
TUSTIN, Calif.--(BUSINESS WIRE)-- #dividends--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/13/2024 02/29/2024 $ 0.3000000 $ 0.2649.
Sabra Health Care REIT: Buy Into Future Demand For Skilled Nursing Facilities
Sabra Health Care REIT gets rated buy, agreeing with consensus, and driven heavily by macro-level demand forecasts for skilled nursing facilities. The stock is undervalued on forward P/FFO vs key peers, and is trading close to its moving average now. The firm has investment-grade ratings from Fitch and Moody's agencies.
Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year
With the FED's rate cut predictions for 2025, Sabra Health Care REIT offers a buying opportunity for long-term investors, especially retirees and income investors. Sabra's solid fundamentals, including improved occupancy rates and a safe 6% dividend yield, make it an attractive investment despite recent market sell-offs. The REIT's balance sheet has strengthened, with Moody's upgrading their outlook to positive, indicating potential for future investment opportunities and price appreciation.
Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate
Sabra Health Care REIT offers a compelling investment opportunity with a reasonable valuation, trading at 13.6x 2024 FFO and 12.9x 2025 FFO. The company benefits from strong industry fundamentals, including an aging population and growing demand for senior living and healthcare facilities. Q3'24 results showed robust performance with occupancy gains and NOI growth, particularly in the SHOP portfolio, indicating effective operational leverage.
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating
TUSTIN, Calif.--(BUSINESS WIRE)-- #Moodys--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that Moody's Ratings (“Moody's”) issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to “Positive” from “Stable”. The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional informat.
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.
Sabra Health Care REIT, Inc. to Attend Fall Conferences
TUSTIN, Calif.--(BUSINESS WIRE)-- #asha--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's.
Sabra Health Care REIT: Turning The Corner
Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.
10 Sweet REITs: Yield Up To 6.6%
Equity REITs, distinct from mortgage REITs, generate income from rental leases and capital appreciation, offering high yields and tax advantages by distributing 90% of taxable income. My portfolio, Rose's Income Garden (RIG), includes six of the ten highlighted REITs, chosen for their credit ratings, yields, and growth potential. Interest rates significantly impact REIT prices; current high valuations may not last, but lower rates could enhance future pricing and investment opportunities.
Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #BAML--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for SBRA.